BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23689360)

  • 1. Impairment in natural killer cells editing of immature dendritic cells by infection with a virulent Trypanosoma cruzi population.
    Batalla EI; Pino Martínez AM; Poncini CV; Duffy T; Schijman AG; González Cappa SM; Alba Soto CD
    J Innate Immun; 2013; 5(5):494-504. PubMed ID: 23689360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
    Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
    Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 participates in the expansion and functional activation of CD8
    Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
    J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.
    Ouaissi A; Guilvard E; Delneste Y; Caron G; Magistrelli G; Herbault N; Thieblemont N; Jeannin P
    J Immunol; 2002 Jun; 168(12):6366-74. PubMed ID: 12055254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of migration and maturation of dendritic cells and T-cell depletion in the course of experimental Trypanosoma cruzi infection.
    Chaussabel D; Pajak B; Vercruysse V; Bisseyé C; Garzé V; Habib M; Goldman M; Moser M; Vray B
    Lab Invest; 2003 Sep; 83(9):1373-82. PubMed ID: 13679445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner.
    Alba Soto CD; Mirkin GA; Solana ME; González Cappa SM
    Infect Immun; 2003 Mar; 71(3):1194-9. PubMed ID: 12595432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory Effect of
    Gutierrez BC; Lammel E; Ramirez MI; González-Cappa SM; Poncini CV
    Front Cell Infect Microbiol; 2020; 10():20. PubMed ID: 32175284
    [No Abstract]   [Full Text] [Related]  

  • 10. The First Contact of Human Dendritic Cells With
    Gil-Jaramillo N; Rocha AP; Raiol T; Motta FN; Favali C; Brigido MM; Bastos IMD; Santana JM
    Front Immunol; 2021; 12():638020. PubMed ID: 33897690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi.
    Koga R; Hamano S; Kuwata H; Atarashi K; Ogawa M; Hisaeda H; Yamamoto M; Akira S; Himeno K; Matsumoto M; Takeda K
    J Immunol; 2006 Nov; 177(10):7059-66. PubMed ID: 17082622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms.
    Poncini CV; Ilarregui JM; Batalla EI; Engels S; Cerliani JP; Cucher MA; van Kooyk Y; González-Cappa SM; Rabinovich GA
    J Immunol; 2015 Oct; 195(7):3311-24. PubMed ID: 26324777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.
    Melki MT; Saïdi H; Dufour A; Olivo-Marin JC; Gougeon ML
    PLoS Pathog; 2010 Apr; 6(4):e1000862. PubMed ID: 20419158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms.
    Lieke T; Graefe SE; Klauenberg U; Fleischer B; Jacobs T
    Infect Immun; 2004 Dec; 72(12):6817-25. PubMed ID: 15557602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi.
    Une C; Andersson J; Orn A
    Clin Exp Immunol; 2003 Nov; 134(2):195-201. PubMed ID: 14616777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection.
    Antúnez MI; Cardoni RL
    Exp Parasitol; 2004; 106(3-4):85-94. PubMed ID: 15172215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of natural killer (NK) cell cytotoxicity and induction of NK cell-derived interferon-gamma (IFN-gamma) display different kinetics during experimental infection with Trypanosoma cruzi.
    Une C; Andersson J; Eloranta ML; Sunnemark D; Harris RA; Orn A
    Clin Exp Immunol; 2000 Sep; 121(3):499-505. PubMed ID: 10971517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn SJ
    Int Immunol; 2005 May; 17(5):607-13. PubMed ID: 15802307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi.
    Miyahira Y; Katae M; Takeda K; Yagita H; Okumura K; Kobayashi S; Takeuchi T; Kamiyama T; Fukuchi Y; Aoki T
    Infect Immun; 2003 Mar; 71(3):1234-41. PubMed ID: 12595437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.